rs2412065

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_002083.4(GPX2):​c.223-1101G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.265 in 152,120 control chromosomes in the GnomAD database, including 6,119 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.27 ( 6119 hom., cov: 32)

Consequence

GPX2
NM_002083.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.72

Publications

20 publications found
Variant links:
Genes affected
GPX2 (HGNC:4554): (glutathione peroxidase 2) The protein encoded by this gene belongs to the glutathione peroxidase family, members of which catalyze the reduction of organic hydroperoxides and hydrogen peroxide (H2O2) by glutathione, and thereby protect cells against oxidative damage. Several isozymes of this gene family exist in vertebrates, which vary in cellular location and substrate specificity. This isozyme is predominantly expressed in the gastrointestinal tract (also in liver in human), is localized in the cytoplasm, and whose preferred substrate is hydrogen peroxide. Overexpression of this gene is associated with increased differentiation and proliferation in colorectal cancer. This isozyme is also a selenoprotein, containing the rare amino acid selenocysteine (Sec) at its active site. Sec is encoded by the UGA codon, which normally signals translation termination. The 3' UTRs of selenoprotein mRNAs contain a conserved stem-loop structure, designated the Sec insertion sequence (SECIS) element, that is necessary for the recognition of UGA as a Sec codon, rather than as a stop signal. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jul 2016]
CHURC1-FNTB (HGNC:42960): (CHURC1-FNTB readthrough) This locus represents naturally occurring read-through transcription between the neighboring CHURC1 (churchill domain containing 1) and FNTB (farnesyltransferase, CAAX box, beta) on chromosome 14. The read-through transcript produces a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Feb 2011]
CHURC1 (HGNC:20099): (churchill domain containing 1) Predicted to enable zinc ion binding activity. Predicted to be involved in positive regulation of transcription, DNA-templated. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.401 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002083.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPX2
NM_002083.4
MANE Select
c.223-1101G>C
intron
N/ANP_002074.2
CHURC1-FNTB
NM_001202559.1
c.327+14859C>G
intron
N/ANP_001189488.1
CHURC1-FNTB
NM_001202558.2
c.6+16813C>G
intron
N/ANP_001189487.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPX2
ENST00000389614.6
TSL:1 MANE Select
c.223-1101G>C
intron
N/AENSP00000374265.5
CHURC1-FNTB
ENST00000549987.1
TSL:2
c.246+14859C>G
intron
N/AENSP00000447121.2
GPX2
ENST00000553522.1
TSL:1
n.223-741G>C
intron
N/AENSP00000450991.1

Frequencies

GnomAD3 genomes
AF:
0.265
AC:
40229
AN:
152002
Hom.:
6094
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.406
Gnomad AMI
AF:
0.373
Gnomad AMR
AF:
0.205
Gnomad ASJ
AF:
0.303
Gnomad EAS
AF:
0.130
Gnomad SAS
AF:
0.293
Gnomad FIN
AF:
0.232
Gnomad MID
AF:
0.217
Gnomad NFE
AF:
0.203
Gnomad OTH
AF:
0.237
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.265
AC:
40317
AN:
152120
Hom.:
6119
Cov.:
32
AF XY:
0.267
AC XY:
19818
AN XY:
74362
show subpopulations
African (AFR)
AF:
0.406
AC:
16854
AN:
41482
American (AMR)
AF:
0.205
AC:
3136
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.303
AC:
1050
AN:
3470
East Asian (EAS)
AF:
0.130
AC:
675
AN:
5190
South Asian (SAS)
AF:
0.292
AC:
1408
AN:
4818
European-Finnish (FIN)
AF:
0.232
AC:
2452
AN:
10584
Middle Eastern (MID)
AF:
0.229
AC:
67
AN:
292
European-Non Finnish (NFE)
AF:
0.203
AC:
13827
AN:
67962
Other (OTH)
AF:
0.241
AC:
509
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1469
2938
4406
5875
7344
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
400
800
1200
1600
2000
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.237
Hom.:
601
Bravo
AF:
0.270
Asia WGS
AF:
0.259
AC:
900
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
11
DANN
Benign
0.44
PhyloP100
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2412065; hg19: chr14-65407657; API